BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 9408347)

  • 1. Distribution of calcitonin-containing parafollicular cells of the thyroid in patients with chronic lymphocytic thyroiditis: a clinical, pathological and immunohistochemical study.
    Lukács G; Sápy Z; Gyóry F; Tóth V; Balázs G
    Acta Chir Hung; 1997; 36(1-4):204-6. PubMed ID: 9408347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of calcitonin- and somatostatin-containing cells in thyroid lymphoma and in Hashimoto's thyroiditis.
    Baschieri L; Castagna M; Fierabracci A; Antonelli A; Del Guerra P; Squartini F
    Appl Pathol; 1989; 7(2):99-104. PubMed ID: 2567176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-cells: current concepts on normal histology and hyperplasia.
    Borda A; Berger N; Turcu M; Al Jaradi M; Vereş S
    Rom J Morphol Embryol; 1999-2004; 45():53-61. PubMed ID: 15847379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities.
    Perry A; Molberg K; Albores-Saavedra J
    Cancer; 1996 Feb; 77(4):750-6. PubMed ID: 8616768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.
    Prasad ML; Huang Y; Pellegata NS; de la Chapelle A; Kloos RT
    Histopathology; 2004 Jul; 45(1):39-46. PubMed ID: 15228442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Her2/neu expression in C-cell hyperplasia and medullary thyroid carcinomas.
    Ensinger C; Prommegger R; Kendler D; Gabriel M; Spizzo G; Mikuz G; Kremser R
    Anticancer Res; 2003; 23(3B):2241-3. PubMed ID: 12894498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hashimoto's thyroiditis with medullary carcinoma.
    Gaskin D; Parai SK; Parai MR
    Can J Surg; 1992 Oct; 35(5):528-30. PubMed ID: 1356609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostatin.
    Scopsi L; Di Palma S; Ferrari C; Holst JJ; Rehfeld JF; Rilke F
    Mod Pathol; 1991 May; 4(3):297-304. PubMed ID: 1676840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preventive total thyroidectomy in children with MEN IIa syndrome].
    Schmid T; Mühlig HP; Spelsberg F
    Chirurg; 1994 Jan; 65(1):48-9. PubMed ID: 7908621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic C-cell hyperplasia associated with chronic lymphocytic thyroiditis.
    Biddinger PW; Brennan MF; Rosen PP
    Am J Surg Pathol; 1991 Jun; 15(6):599-604. PubMed ID: 1674409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-cell hyperplasia and medullary thyroid carcinoma in the rat. An immunohistochemical and ultrastructural analysis.
    DeLellis RA; Nunnemacher G; Bitman WR; Gagel RF; Tashjian AH; Blount M; Wolfe HJ
    Lab Invest; 1979 Feb; 40(2):140-54. PubMed ID: 431034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary carcinoma of the thyroid gland with sustentacular cell-like cells in a patient with multiple endocrine neoplasia, type IIA. Report of a case with ultrastructural and immunohistochemical studies.
    Collina G; Maiorana A; Fano RA; Cesinaro AM; Trentini GP
    Arch Pathol Lab Med; 1994 Oct; 118(10):1041-4. PubMed ID: 7944893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medullary thyroid carcinoma and some of its particularities].
    Sidibé el H
    Sante; 2007; 17(1):51-5. PubMed ID: 17897902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
    Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
    Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic medullary thyroid carcinoma associated with toxic multinodular goitre.
    Small PK; Smith D
    J R Coll Surg Edinb; 1997 Jun; 42(3):199-200. PubMed ID: 9195818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic features of Hashimoto's-associated papillary thyroid carcinomas.
    Di Pasquale M; Rothstein JL; Palazzo JP
    Hum Pathol; 2001 Jan; 32(1):24-30. PubMed ID: 11172291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-cell hyperplasia preceding medullary thyroid carcinoma.
    Wolfe HJ; Melvin KE; Cervi-Skinner SJ; Saadi AA; Juliar JF; Jackson CE; Tashjian AH
    N Engl J Med; 1973 Aug; 289(9):437-41. PubMed ID: 4587234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.